跳至主要内容
临床试验/IRCT201211051743N10
IRCT201211051743N10已完成未知

A double-blind, placebo-controlled study on the efficacy of risperidone adjunctive to methylphenidate in patients with ADHD

Research center for behavioral disorders and substance abuse, Hamadan University of Medical Science0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 12 years(—)
性别
All

入选标准

  • Inclusion Criteria: Diagnosed as ADHD according to DSM-IV TR and conner's scale; Age between 6 to12years; No other psychiatric disorders along with ADHD; No other debilitating physical illness along with ADHD; IQ>70

排除标准

  • Severe drug complication during the study; abnormal labratory tests (BC,NA,K,BS,BUN,CR,TSH,AST,ALT,PRL,TOT CHOL,LDL CHOL,HDL,CHOL,TG).

研究者

发起方
Research center for behavioral disorders and substance abuse, Hamadan University of Medical Science

相似试验

efficacy of risperidone in ADHD | 临床试验